PRQR NASDAQ
ProQR Therapeutics N.V.
1W: -0.6%
1M: -23.7%
3M: -4.7%
YTD: -17.6%
1Y: -24.1%
3Y: +18.8%
5Y: -79.0%
$1.64
+0.01 (+0.31%)
Weekly Expected Move ±6.4%
$1
$2
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$113M
-32.9% ▼
5Y CAGR: -1.4%
Total Liabilities
$63M
-20.2% ▼
5Y CAGR: +4.2%
Shareholders Equity
$49M
-44.3% ▼
5Y CAGR: -6.7%
Cash & Investments
$92M
-38.2% ▼
5Y CAGR: -0.1%
Total Debt
$14M
-18.8% ▼
5Y CAGR: -19.7%
Net Debt
-$78M
+40.7% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $188M | $95M | $131M | $149M | $92M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $188M | $95M | $131M | $149M | $92M |
| Net Receivables | $0 | $56M | $1M | $0 | $5M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $823K | $982K | $0 | $2M | $0 |
| Total Current Assets | $191M | $154M | $134M | $154M | $100M |
| Property, Plant & Equip. | $17M | $16M | $19M | $14M | $13M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $629K | $621K | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $1 | $0 | $0 | $0 |
| Total Non-Current Assets | $18M | $17M | $19M | $14M | $13M |
| Total Assets | $210M | $171M | $152M | $168M | $113M |
| — Liabilities — | |||||
| Accounts Payable | $191K | $392K | $2M | $16K | $298K |
| Short-Term Debt | $5M | $2M | $2M | $5M | $4M |
| Deferred Revenue | $0 | $0 | $23M | $0 | $18M |
| Other Current Liabilities | $20M | $16M | $12M | $31M | $10M |
| Total Current Liabilities | $28M | $21M | $38M | $39M | $32M |
| Long-Term Debt | $39M | $4M | $5M | $0 | $0 |
| Other Non-Current Liab. | $15M | $66M | $0 | $29M | $0 |
| Total Non-Current Liabilities | $69M | $84M | $69M | $40M | $31M |
| Total Liabilities | $96M | $105M | $107M | $79M | $63M |
| — Equity — | |||||
| Common Stock | $3M | $3M | $4M | $4M | $4M |
| Retained Earnings | -$318M | -$379M | -$443M | -$427M | -$467M |
| Accumulated OCI | $30M | $30M | $29M | $28M | $29M |
| Total Stockholders Equity | $114M | $67M | $46M | $89M | $49M |
| Total Liabilities & Equity | $210M | $171M | $152M | $168M | $113M |
| — Key Metrics — | |||||
| Total Debt | $60M | $22M | $22M | $17M | $14M |
| Net Debt | -$127M | -$73M | -$110M | -$132M | -$78M |
| Total Investments | $629K | $621K | $0 | $0 | $0 |